141 related articles for article (PubMed ID: 11118024)
1. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
Araki S; Moczulski DK; Hanna L; Scott LJ; Warram JH; Krolewski AS
Diabetes; 2000 Dec; 49(12):2190-5. PubMed ID: 11118024
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
[TBL] [Abstract][Full Text] [Related]
3. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2 diabetes.
Satirapoj B; Supasyndh O; Dispan R; Punpanich D; Tribanyatkul S; Choovichian P
J Med Assoc Thai; 2013 Sep; 96(9):1119-26. PubMed ID: 24163986
[TBL] [Abstract][Full Text] [Related]
5. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus.
Moczulski DK; Scott L; Antonellis A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
Diabet Med; 2000 Feb; 17(2):111-8. PubMed ID: 10746480
[TBL] [Abstract][Full Text] [Related]
7. APOE polymorphism and diabetic nephropathy.
Araki S
Clin Exp Nephrol; 2014 Apr; 18(2):230-3. PubMed ID: 24026386
[TBL] [Abstract][Full Text] [Related]
8. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
[TBL] [Abstract][Full Text] [Related]
9. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotyping in Egyptian diabetic nephropathy patients.
Atta MI; Abo Gabal K; El-Hadidi K; Swellam M; Genina A; Zaher NF
IUBMB Life; 2016 Jan; 68(1):58-64. PubMed ID: 26662731
[TBL] [Abstract][Full Text] [Related]
11. Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.
Jiang Y; Ma L; Han C; Liu Q; Cong X; Xu Y; Zhao T; Li P; Cao Y
J Diabetes Res; 2017; 2017():3560920. PubMed ID: 28326331
[TBL] [Abstract][Full Text] [Related]
12. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.
Li Y; Tang K; Zhang Z; Zhang M; Zeng Z; He Z; He L; Wan C
Mol Biol Rep; 2011 Jun; 38(5):3243-52. PubMed ID: 20177792
[TBL] [Abstract][Full Text] [Related]
13. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.
Araki S; Ng DP; Krolewski B; Wyrwicz L; Rogus JJ; Canani L; Makita Y; Haneda M; Warram JH; Krolewski AS
J Am Soc Nephrol; 2003 Aug; 14(8):2015-24. PubMed ID: 12874455
[TBL] [Abstract][Full Text] [Related]
14. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
15. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
16. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
[TBL] [Abstract][Full Text] [Related]
17. Association study between apolipoprotein E gene polymorphism and diabetic nephropathy in a Taiwanese population.
Wen MJ; Lin CJ; Hung YJ; Pei D; Kuo SW; Hsieh CH
Genet Test Mol Biomarkers; 2011 Oct; 15(10):685-9. PubMed ID: 21689001
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between the ApoE Gene Polymorphism and Type 2 Diabetes Mellitus Complications.
Gao C; Fu X; Chu Q; Li J; Shu G
Genet Test Mol Biomarkers; 2021 Feb; 25(2):111-115. PubMed ID: 33596139
[No Abstract] [Full Text] [Related]
19. Apo E gene polymorphism on development of diabetic nephropathy.
Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.
Tarnow L; Stehouwer CD; Emeis JJ; Poirier O; Cambien F; Hansen BV; Parving HH
Nephrol Dial Transplant; 2000 May; 15(5):625-30. PubMed ID: 10809802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
